Prescription costs with Medicare

How much does Jardiance cost with Medicare in Colorado in 2027?

Jardiance has a Medicare negotiated price of $202.33 for a 30-day supply in 2027, which comes to about $1,132 for the year under the 2027 standard Part D design if it is your only drug, with all covered drug costs capped at $2,400, and Colorado Part D members paid an average of $37.11 per 30-day fill in 2024.

Talk to a licensed agent (303) 887-8584

Jardiance (empagliflozin) is an SGLT2 inhibitor: it helps the kidneys pass extra glucose in the urine. CMS lists three conditions it commonly treats: type 2 diabetes, heart failure and chronic kidney disease. That is why a cardiologist, a kidney specialist or a family doctor may each prescribe it; 6,203 Colorado prescribers wrote it for 32,287 Part D members in 2024. In Adams County, 9.7% of adults have diagnosed diabetes, per CDC PLACES.

Jardiance under Medicare Part D in 2027: price, yearly cost and Colorado figures
JardianceAmount
Medicare negotiated price, 30 days (2027)$202.33
What changed: the 2026 negotiated price$197
Jardiance alone for a year, 2027 standard design$1,131.99
Jardiance plus Eliquis for a year, 2027 standard design$1,843.74
Colorado Part D members who filled Jardiance (2024)32,287
Colorado gross cost per 30-day fill (2024)$484.30
Colorado patient share per 30-day fill (2024)$37.11
Source: CMS Colorado Part D data for 2024 (gross cost before rebates), the CMS negotiated price data file (September 2026) for 2027 prices, and the CMS CY2027 Rate Announcement for the 2027 standard design. Full citations below.

Why Jardiance is on so many medication lists

Because it treats three common conditions, Jardiance reached 1,883,000 Part D enrollees and $8.8 billion in gross spending nationally in 2023, according to CMS. Its negotiated price, $197 in 2026, rises with inflation to $202.33 for 2027 in the CMS price file, still far below the $573 list price. National Part D data show average gross spending per empagliflozin claim of $1,091.19 in 2025 and $386.83 in the first quarter of 2026.

No generic empagliflozin yet

No empagliflozin entry appears on the FDA First Generic Drug Approvals lists for 2024, 2025 or 2026, the last checked through its October 5, 2026 update. Its close relative Farxiga received first generic approvals in April 2026, but that does not make empagliflozin interchangeable with dapagliflozin; switching between them is a prescriber decision. CMS lists no removal for Jardiance, so brand Jardiance keeps its negotiated price into 2027.

Jardiance on its own, and stacked with other brands

On a 2027 plan with the $700 deductible and 25% coinsurance, the first three fills cost $202.33 each, April costs $120.34, and the remaining 8 months run $50.58 apiece: $1,131.99 for 2027.

Many people taking Jardiance also take a blood thinner. Add Eliquis at its $237.25 2027 negotiated price and the 2027 total for both is about $1,843.74. One more brand-name drug could push you to the $2,400 limit, after which covered Part D drugs cost $0 for the rest of the year.

Lowering what you pay

Extra Help removes the deductible and caps brand-name copays at $14.40 per fill for 2027; twelve fills would be $172.80. The 2026 limits are $23,940 of income and $18,090 of resources for a single person. CMS also suggests asking the drug maker whether it offers help, and a plan with a $0 drug deductible changes the early months more than anything else.

Questions to bring to a Jardiance plan review

Bring the strength printed on your bottle, since Jardiance comes as 10 mg and 25 mg tablets. Then ask each plan four things: which tier holds Jardiance, whether step therapy means trying metformin or another drug first, whether a 90-day supply through a preferred or mail-order pharmacy lowers the monthly share, and whether your current pharmacy in Brighton, Thornton or Commerce City is preferred or merely in network.

Colorado totals give a sense of scale: 263,852 thirty-day fills in 2024, $127,784,093 gross, of which members paid $9,790,666.

Where the deductible changes everything

In the 2027 Adams County file, 6 of the 31 Medicare Advantage plans with drug coverage have a $0 drug deductible. On a plan like that, with 25% coinsurance and the $202.33 price, twelve Jardiance fills would run $606.99, against roughly $1,132 on a plan using the full $700 deductible. Real plans use tier copays, so treat this as a direction, then price the actual formulary.

Related questions

How much does Jardiance cost with Medicare in Colorado in 2027?

Jardiance has a Medicare negotiated price of $202.33 for a 30-day supply in 2027, which comes to about $1,132 for the year under the 2027 standard Part D design if it is your only drug, with all covered drug costs capped at $2,400, and Colorado Part D members paid an average of $37.11 per 30-day fill in 2024.

Headwaters checks this for you before you decide. Call Lisa at (303) 887-8584.

Is Jardiance one of the Medicare negotiated drugs in 2027?

Yes. It was in the first group of ten, CMS lists no removal, and its negotiated price for 2027 is $202.33 for 30 days, up from $197 in 2026 after the inflation adjustment. Lisa checks how this applies to your own doctors and prescriptions at no cost. Call (303) 887-8584.

Is there a generic Jardiance?

Not as of October 2026. Empagliflozin does not appear on the FDA first generic approval lists for 2024 through 2026, and CMS lists no removal for Jardiance. Lisa walks you through this at your review. Call (303) 887-8584.

Will Medicare cover Jardiance for heart failure or kidney disease without diabetes?

CMS lists heart failure and chronic kidney disease among the conditions Jardiance commonly treats. Whether your plan covers it, and whether prior authorization applies, is set by each plan formulary, so check your 2027 drug list. Headwaters checks this for you before you decide. Call Lisa at (303) 887-8584.

Sources

  1. CMS Selected Drug List and Negotiated Prices (Maximum Fair Price) data file, September 21, 2026 Centers for Medicare & Medicaid Services
  2. CMS Announcement of Calendar Year 2027 Medicare Advantage Capitation Rates and Part C and Part D Payment Policies Centers for Medicare & Medicaid Services
  3. CMS Medicare Part D Prescribers by Geography and Drug, 2024 (Colorado) Centers for Medicare & Medicaid Services
  4. CMS fact sheet: negotiated prices for initial price applicability year 2026 Centers for Medicare & Medicaid Services
  5. CMS Medicare Quarterly Part D Spending by Drug Centers for Medicare & Medicaid Services
  6. CMS: How much does Medicare drug coverage cost? Centers for Medicare & Medicaid Services
  7. FDA: First Generic Drug Approvals (2026) U.S. Food and Drug Administration
  8. FDA: 2025 First Generic Drug Approvals U.S. Food and Drug Administration
  9. CMS: Help with drug costs (Extra Help) Centers for Medicare & Medicaid Services
  10. CDC PLACES: Local Data for Better Health, County Data (2025 release) Centers for Disease Control and Prevention

Please note: We do not offer every plan available in your area. Currently we represent 10 organizations which offer 106 products in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options.Headwaters Health and Wealth is not connected with or endorsed by the United States government or the federal Medicare program. Medicare has neither endorsed nor reviewed this information.

Take the stress out of Medicare.

Book a free, no-obligation review with Lisa in Brighton, by phone or by video. Bring your questions; leave with answers.

992 South Fourth Avenue, Brighton, CO 80601 · (303) 887-8584

Content reviewed by Lisa Asmussen, Medicare Broker and Licensed Insurance Agent at Headwaters Health and Wealth in Brighton, Colorado, certified to sell Medicare plans since 2018 (8 years). How we source and review our content. Last updated .